By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 January 2025 The round table discussion at MultiPark retreat 2024. Photo: Megg Garcia-Ryde. Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this y

https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 6 February 2025 In the podcast "Meet Our Scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Illustration:Emma Nyberg. Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader,

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 21 January 2025 Contributing to a real research project in one of MultiPark's research groups is an essential part of the Advanced Neuroscience course. Photo: Angela Cenci Nilsson. This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world uni

https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 13 February 2025 Experimental scientist Ilknur Özen and Niklas Marklund, professor at Lund University and neurosurgical consultant at Skåne University hospital have in collaboration with Uppsala investigated brain tissue from 15 patients. Photo: Tove Smeds A study at Lund University reveals that traumatic brain inj

https://www.multipark.lu.se/article/cracking-alzheimers-code-how-brain-trauma-triggers-disease - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 14 March 2025 Photo: Emma Nyberg. This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 2 April 2025 Photo: Emma Nyberg. What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced dis

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2025-07-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 14 April 2025 Professor Oskar Hansson, professor in neurology at Lund University. Photo: Tove Smeds Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to bene

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2025-07-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 15 April 2025 “Even with the simpler method of analysis, the blood test gives highly accurate results for Alzheimer’s disease pathology,” says Sebastian Palmqvist, associate professor and senior lecturer in neurology at Lund University. Photo: iStock A simpler method of analysing blood samples for Alzheimer’s disease has been

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 22 May 2025 In the podcast "Meet Our Scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Illustration:Emma Nyberg. Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the bloo

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline - 2025-07-09

By emma [dot] nyberg [at] med [dot] lu [dot] se (Emma Nyberg) - published 4 June 2025 First and last authors Sofia Bergh and Åsa Petersen at the prestigious Gordon Research Conference for CAG Triplet Repeat Disorders in May, 2025 in Italy. Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the

https://www.multipark.lu.se/article/protein-mismanagement-brains-control-center-fuels-early-symptoms-neurodegenerative-diseases - 2025-07-09

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 26 June 2025 The researchers stained brain sections to identify how different Parkinson’s treatments activate distinct brain circuits. Photo: Emma Nyberg. An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could e

https://www.multipark.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2025-07-09

Published 3 April 2019 How do you stop Alzheimer’s disease without a simple way to diagnose it? It’s a real chicken and egg problem, as I wrote last year on TGN. Discovering a treatment for Alzheimer’s requires lots of clinical trials for new drugs—but it’s difficult to enroll participants without a way to identify people who have the disease early enough for potential treatments to work. Read the

https://www.multipark.lu.se/article/unexpected-way-we-might-one-day-diagnose-alzheimers - 2025-07-09

Published 23 April 2019 A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. Recently published in JAMA Neurology, the study suggests that the NFL concentration in the blood could be able to indicate if a drug actually

https://www.multipark.lu.se/article/more-evidence-blood-tests-can-detect-risk-alzheimers - 2025-07-09

Published 21 May 2019 In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene that produces this protein in mice, the amount of Alzheimer’s

https://www.multipark.lu.se/article/researchers-block-protein-plays-key-role-alzheimers-disease - 2025-07-09

Published 27 May 2019 Daniella was awarded the prize for "successful effort as a young researcher and group leader". Link to Jeanssons Foundation website (in Swedish)

https://www.multipark.lu.se/article/daniella-ottosson-receives-prize-jeanssons-foundation - 2025-07-09

Published 10 June 2019 The Future Faculty is proud to present the 2019 Minerva Award to Tomas Deierborg, associate professor at the Department of Experimental Medical Sciences.The Minerva award selection committee's motivation for the choice is: "The core values of the Minerva award are honesty, trust, fairness, respect, responsibility and courage. From the nominations it is obvious that Tomas Dei

https://www.multipark.lu.se/article/minerva-award-tomas-deierborg - 2025-07-09

Published 25 June 2019 In today’s JAMA Neurology, researchers led by Oskar Hansson, Lund University, Sweden, report how a fully automated immunoassay for plasma Aβ performed when they put it through its paces. Roche Diagnostic’s Elecsys system predicted Aβ-positive individuals with about 80 percent accuracy. That number improved by 5 percent when the researchers took ApoE genotype into considerati

https://www.multipark.lu.se/article/drawing-closer-alzheimers-blood-test-primary-care - 2025-07-09

Published 6 August 2019 Scientists are becoming more nuanced in how they use amyloid scans—not just to detect the presence of Alzheimer’s pathology, but also to pinpoint disease stage. At this year’s Alzheimer’s Association International Conference, held July 13–18 in Los Angeles, researchers led by Niklas Mattsson and Oskar Hansson at Lund University, Sweden, debuted a new staging scheme. Read th

https://www.multipark.lu.se/article/new-pet-staging-scheme-amyloid - 2025-07-09

Published 4 November 2019 Event organizers: Kajsa Brolin (representing Maria Swanberg), Gerard Müller (ParkinsonSkåne chair), Angela Cenci Nilsson, Georg Stenberg (lecturer and person with Parkinson), Andreas Heuer On October 30, MultiPark arranged, in collaboration with the Parkinson Skåne patient organization and Studieförbundet Vuxenskolan, a half-day study visit for the public to the Biomedica

https://www.multipark.lu.se/article/parkinson-skane-visits-bmc - 2025-07-09

Published 21 November 2019 Oskar Hansson, professor of neurology at Lund University and cheif physician at Skåne University Hospital, is included in this year´s list of highly cited researchers that Web of Science compiles each year.Read the article (in Swedish) on the Faculty of Medicine website.

https://www.multipark.lu.se/article/congratulations-oskar-hansson-list-highly-cited-2019 - 2025-07-09